We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAdalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.AuthorsSandborn, W J; Hanauer, S B; Rutgeerts, P; Fedorak, R N; Lukas, M; MacIntosh, D G; Panaccione, R; Wolf, D; Kent, J D; Bittle, B; Li, J; Pollack, P FAbstractAdalimumab induced clinical remission after four weeks in patients with active Crohn's disease in the CLASSIC I trial.PublicationGut, 2007, Vol 56, Issue 9, p1232ISSN0017-5749Publication typeJournal ArticleDOI10.1136/gut.2006.106781